|
|
||||||||
Supplements |
1 From the Division of Hepatology and Gene Therapy, School of Medicine, University of Navarra, Pamplona, Spain.
One of the features of liver cirrhosis is an abnormal metabolism of methioninea characteristic that was described more than a half a century ago. Thus, after an oral load of methionine, the rate of clearance of this amino acid from the blood is markedly impaired in cirrhotic patients compared with that in control subjects. Almost 15 y ago we observed that the failure to metabolize methionine in cirrhosis was due to an abnormally low activity of the enzyme methionine adenosyltransferase (EC 2.5.1.6). This enzyme converts methionine, in the presence of ATP, to S-adenosyl-L-methionine (SAMe), the main biological methyl donor. Since then, it has been suspected that a deficiency in hepatic SAMe may contribute to the pathogenesis of the liver in cirrhosis. The studies reviewed here are consistent with this hypothesis.
Key Words: Methionine S-adenosyl-l-methionine SAMe methionine adenosyltransferase liver injury liver regeneration cirrhosis oxidative stress protein S-nitrosylation
This article has been cited by other articles:
![]() |
A. Sahai, P. Malladi, H. Melin-Aldana, R. M. Green, and P. F. Whitington Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G264 - G273. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S Lieber and L. Packer S-Adenosylmethionine: molecular, biological, and clinical aspects--an introduction Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1148S - 1150S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mischoulon and M. Fava Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1158S - 1161S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |